Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$185.1 - $233.13 $2,961 - $3,730
16 Added 1.02%
1,581 $365,000
Q3 2023

Nov 08, 2023

SELL
$233.08 - $265.59 $4,661 - $5,311
-20 Reduced 1.26%
1,565 $388,000
Q2 2023

Aug 14, 2023

BUY
$224.99 - $256.14 $23,173 - $26,382
103 Added 6.95%
1,585 $380,000
Q1 2023

May 11, 2023

SELL
$239.75 - $277.0 $60,417 - $69,804
-252 Reduced 14.53%
1,482 $373,000
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $1,931 - $2,258
-8 Reduced 0.46%
1,734 $460,000
Q3 2022

Nov 09, 2022

SELL
$247.06 - $1507.4 $6,176 - $37,685
-25 Reduced 1.41%
1,742 $450,000
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $514 - $631
-2 Reduced 0.11%
1,767 $518,000
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $2,044 - $2,303
-7 Reduced 0.39%
1,769 $582,000
Q3 2021

Nov 12, 2021

BUY
$272.21 - $332.43 $40,287 - $49,199
148 Added 9.09%
1,776 $541,000
Q3 2020

Nov 10, 2020

SELL
$177.16 - $215.33 $53,148 - $64,599
-300 Reduced 15.56%
1,628 $351,000
Q2 2020

Aug 13, 2020

SELL
$128.7 - $176.83 $75,418 - $103,622
-586 Reduced 23.31%
1,928 $341,000
Q1 2020

May 14, 2020

SELL
$121.39 - $169.05 $21,486 - $29,921
-177 Reduced 6.58%
2,514 $348,000
Q4 2019

Feb 03, 2020

BUY
$133.47 - $153.48 $34,702 - $39,904
260 Added 10.7%
2,691 $413,000
Q3 2019

Nov 14, 2019

SELL
$135.4 - $146.47 $40,620 - $43,941
-300 Reduced 10.98%
2,431 $351,000
Q1 2019

May 13, 2019

SELL
$97.62 - $132.29 $52,421 - $71,039
-537 Reduced 16.43%
2,731 $361,000
Q4 2018

Feb 11, 2019

BUY
$94.85 - $109.54 $3,130 - $3,614
33 Added 1.02%
3,268 $337,000
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $20,018 - $22,215
204 Added 6.73%
3,235 $352,000
Q2 2018

Aug 13, 2018

SELL
$96.1 - $103.24 $43,148 - $46,354
-449 Reduced 12.9%
3,031 $299,000
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $320,716 - $361,224
3,480 New
3,480 $341,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.